Form 4: Nevro Corp Director Shawn McCormick Reports Acquisition and Disposal of Common Stock

Director Shawn McCormick reports acquiring 19,169 shares of Nevro Corp common stock through restricted stock units (RSUs) and disposing of shares.

Summary

• On May 23, 2024, Shawn McCormick, a director of Nevro Corp, reported acquiring 19,169 shares of common stock through restricted stock units (RSUs).
• These RSUs will vest on the earlier of May 23, 2025, or the next Annual Meeting following May 23, 2024, contingent upon continued service to the Issuer.
• McCormick also reported disposing of shares.
• Following these transactions, McCormick beneficially owns 46,035 shares, including 19,169 RSUs.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports transactions without expressing explicit positive or negative views. The acquisition of RSUs is mildly positive, while the disposal of shares is mildly negative, balancing each other out.

Positives

• The acquisition of RSUs by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Negatives

• The disposal of shares by the director could be interpreted negatively by some investors.

Risks

• The vesting of RSUs is contingent upon continued service, creating a potential risk if the director were to leave the company before the vesting date.

Future Outlook

The vesting of RSUs is tied to continued service, suggesting an expectation of ongoing involvement by the director.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key personnel.

Key Dates